Elutia, Inc. (ELUT)

Elutia, Inc. is a medical technology company developing and commercializing biologic products for surgical reconstruction, with a focus on drug-eluting biomatrix technology. Formerly known as Aziyo Biologics, the company adopted the Elutia name in 2023 and is headquartered in Gaithersburg, Maryland.

Its products include SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction, and cardiovascular products such as ProxiCor, Tyke and VasCure, which are used to repair cardiac and vascular tissue in adults and infants. The company's development programs combine biologic scaffolds with local antibiotic delivery to help reduce the risk of surgical infection.

Elutia sells to hospitals and other healthcare facilities, largely through independent sales agents.